{"id":"https://openalex.org/W1982199478","doi":"https://doi.org/10.1038/sj.bjp.0701465","title":"Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists","display_name":"Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists","alternate_titles":[],"publication_year":1997,"publication_date":"1997-11-01","ids":{"openalex":"https://openalex.org/W1982199478","doi":"https://doi.org/10.1038/sj.bjp.0701465","mag":"1982199478","pmid":"https://pubmed.ncbi.nlm.nih.gov/9401787","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1565029"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjp.0701465","doi":"https://doi.org/10.1038/sj.bjp.0701465","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0701465","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0701465","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1982199478"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0701465","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044182242","display_name":"Takuya Maemoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Takuya Maemoto","raw_affiliation_strings":["Fujisawa Institute of Neuroscience, University of Edinburgh, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisawa Institute of Neuroscience, University of Edinburgh, Osaka, Japan","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062356003","display_name":"Keith Finlayson","orcid":"https://orcid.org/0000-0002-0056-3343","observed_orcids":["https://orcid.org/0000-0002-0056-3343"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Keith Finlayson","raw_affiliation_strings":["Department of Pharmacology, University of Edinburgh, Edinburgh EH8 9JZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Edinburgh, Edinburgh EH8 9JZ","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011188240","display_name":"Henry J. Olverman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Henry J. Olverman","raw_affiliation_strings":["Department of Pharmacology, University of Edinburgh, Edinburgh EH8 9JZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Edinburgh, Edinburgh EH8 9JZ","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055464659","display_name":"Atsushi Akahane","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Atsushi Akahane","raw_affiliation_strings":["New Drug Research Laboratories, Fujisawa Pharmaceutical Co. Ltd., Osaka 532, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Drug Research Laboratories, Fujisawa Pharmaceutical Co. Ltd., Osaka 532, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110056062","display_name":"Roger W. Horton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1310053265","display_name":"St George's Hospital","ror":"https://ror.org/0001ke483","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1310053265","https://openalex.org/I2801196673"]},{"id":"https://openalex.org/I165862685","display_name":"St George's, University of London","ror":"https://ror.org/040f08y74","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I165862685","https://openalex.org/I4401726869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Roger W. Horton","raw_affiliation_strings":["Department of Pharmacology, St. George's Hospital Medical School, London, SW17 0RE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, St. George's Hospital Medical School, London, SW17 0RE","institution_ids":["https://openalex.org/I1310053265","https://openalex.org/I165862685"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021691019","display_name":"Steven P. Butcher","orcid":"https://orcid.org/0000-0002-2237-835X","observed_orcids":["https://orcid.org/0000-0002-2237-835X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Steven P. Butcher","raw_affiliation_strings":["Fujisawa Institute of Neuroscience"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisawa Institute of Neuroscience","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5021691019"],"corresponding_institution_ids":[],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.7878,"has_fulltext":true,"cited_by_count":58,"citation_normalized_percentile":{"value":0.63344988,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"122","issue":"6","first_page":"1202","last_page":"1208"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-a1-receptor","display_name":"adenosine A1 receptor","score":0.9900000095367432},{"id":"https://openalex.org/keywords/species-differences","display_name":"species differences","score":0.7459999918937683},{"id":"https://openalex.org/keywords/receptor-pharmacology","display_name":"receptor pharmacology","score":0.6790000200271606},{"id":"https://openalex.org/keywords/dpcpx","display_name":"DPCPX","score":0.8230000138282776},{"id":"https://openalex.org/keywords/neca","display_name":"NECA","score":0.8270000219345093},{"id":"https://openalex.org/keywords/2-chloro-n6-cyclopentyladenosine","display_name":"2-chloro-N6-cyclopentyladenosine","score":0.9369999766349792},{"id":"https://openalex.org/keywords/gpp-nh-p","display_name":"Gpp(NH)p","score":0.8420000076293945},{"id":"https://openalex.org/keywords/gtp-analogues","display_name":"GTP analogues","score":0.3889999985694885},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.5759999752044678},{"id":"https://openalex.org/keywords/binding-site-density","display_name":"binding site density","score":0.7789999842643738},{"id":"https://openalex.org/keywords/cortical-membranes","display_name":"cortical membranes","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.5958274602890015},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.5435154438018799},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5315717458724976},{"id":"https://openalex.org/C2778815084","wikidata":"https://www.wikidata.org/wiki/Q79803","display_name":"Guinea pig","level":2,"score":0.49373993277549744},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.47098490595817566},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.44349661469459534},{"id":"https://openalex.org/C182683403","wikidata":"https://www.wikidata.org/wiki/Q14888579","display_name":"Adenosine A1 receptor","level":5,"score":0.43930357694625854},{"id":"https://openalex.org/C2779470414","wikidata":"https://www.wikidata.org/wiki/Q50980","display_name":"Xanthine","level":3,"score":0.4249381422996521},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.4208722412586212},{"id":"https://openalex.org/C67847695","wikidata":"https://www.wikidata.org/wiki/Q626478","display_name":"Radioligand","level":3,"score":0.4157702922821045},{"id":"https://openalex.org/C2781041448","wikidata":"https://www.wikidata.org/wiki/Q75839","display_name":"Cerebral cortex","level":2,"score":0.41206085681915283},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41153183579444885},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.4093794524669647},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39424675703048706},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38065552711486816},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3417966067790985},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.33518168330192566},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1320774257183075},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.12575241923332214},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.062100619077682495}],"mesh":[{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010627","descriptor_name":"Phenethylamines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010627","descriptor_name":"Phenethylamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014316","descriptor_name":"Tritium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014970","descriptor_name":"Xanthines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014970","descriptor_name":"Xanthines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058915","descriptor_name":"Purinergic P1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1038/sj.bjp.0701465","doi":"https://doi.org/10.1038/sj.bjp.0701465","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0701465","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0701465","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3469889","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1565029","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:9401787","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9401787","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1565029","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1565029/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1038/sj.bjp.0701465","doi":"https://doi.org/10.1038/sj.bjp.0701465","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0701465","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0701465","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.5683000087738037,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1982199478.pdf","grobid_xml":"https://content.openalex.org/works/W1982199478.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W31407392","https://openalex.org/W130778363","https://openalex.org/W1481591305","https://openalex.org/W1484320289","https://openalex.org/W1511164301","https://openalex.org/W1535611266","https://openalex.org/W1542957393","https://openalex.org/W1547703436","https://openalex.org/W1674184175","https://openalex.org/W1753727899","https://openalex.org/W1763645252","https://openalex.org/W1886164324","https://openalex.org/W1914750790","https://openalex.org/W1963827446","https://openalex.org/W1980189014","https://openalex.org/W1988041203","https://openalex.org/W1989417748","https://openalex.org/W2001110103","https://openalex.org/W2003366915","https://openalex.org/W2008862835","https://openalex.org/W2009008028","https://openalex.org/W2015172541","https://openalex.org/W2016941264","https://openalex.org/W2017037026","https://openalex.org/W2031926319","https://openalex.org/W2041366274","https://openalex.org/W2049790354","https://openalex.org/W2050090555","https://openalex.org/W2080267130","https://openalex.org/W2083957810","https://openalex.org/W2107747076","https://openalex.org/W2126155748","https://openalex.org/W2128635872","https://openalex.org/W2159163715","https://openalex.org/W2346314362","https://openalex.org/W2397946209","https://openalex.org/W2414547583","https://openalex.org/W2428696382","https://openalex.org/W4236341500"],"related_works":["https://openalex.org/W2159163715","https://openalex.org/W2031926319","https://openalex.org/W2016941264","https://openalex.org/W2138637465","https://openalex.org/W2089879313","https://openalex.org/W2123172062","https://openalex.org/W1976745787","https://openalex.org/W1974333399","https://openalex.org/W1983223101","https://openalex.org/W2047394221"],"abstract_inverted_index":{"1.":[0],"The":[1,33,83,102,169,190,212,287],"pharmacological":[2],"profile":[3],"of":[4,25,35,105,107,120,185,192,215,298,308],"adenosine":[5,109,195,269,331],"A1":[6,332],"receptors":[7,271],"in":[8,18,39,52,57,90,95,114,129,134,141,156,164,202,240,255,274,283,314,319,337,350],"human,":[9,241,351],"guinea-pig,":[10,242],"rat":[11,40,53,91,130,142,157,203,243,284,320],"and":[12,42,63,67,80,136,143,233,244,262,292,301,311,354],"mouse":[13,65,144,245,353],"brain":[14,138,145,246,356],"membranes":[15,44,55,58,93,132,146,205,258],"was":[16,45,50,88,112,125,147,167,187,198,217,272],"characterized":[17],"a":[19,275],"radioligand":[20],"binding":[21,37,84,253,281,317,348],"assay":[22,282,318],"by":[23],"use":[24],"the":[26,118,183,315],"receptor":[27,110,196,333],"selective":[28,334],"antagonist,":[29],"[3H]-8-cyclopentyl-1,3-dipropylxanthine":[30],"([3H]-DPCPX).":[31],"2.":[32],"affinity":[34,49,124,140,155,163,179,184,191,239,267,345],"[3H]-DPCPX":[36,252,316,347],"sites":[38,254,349],"cortical":[41,54,92,99,131,161,204,257,321],"hippocampal":[43],"similar.":[46,148],"Binding":[47],"site":[48,85],"higher":[51,128,154,201],"than":[56,94,133],"prepared":[59],"from":[60],"guinea-pig":[61,96,137,210,355],"cortex":[62,66],"hippocampus,":[64],"human":[68,98,135,160,208,256],"cortex.":[69],"pKD":[70],"values":[71,249,296,307],"(M)":[72,250,297],"were":[73,259],"9.55,":[74],"9.44,":[75],"8.85,":[76],"8.94,":[77],"8.67,":[78,81],"9.39":[79],"respectively.":[82,264],"density":[86],"(Bmax)":[87],"lower":[89],"or":[97,209],"membranes.":[100,211,247,286,322,357],"3.":[101],"rank":[103,213],"order":[104,214],"potency":[106,216],"seven":[108],"agonists":[111],"identical":[113],"each":[115],"species.":[116],"With":[117],"exception":[119],"5'-N-ethylcarboxamidoadenosine":[121],"(NECA),":[122],"agonist":[123],"3.5-26.2":[126],"fold":[127,153,200],"membranes;":[139],"While":[149],"NECA":[150],"exhibited":[151,237,294],"9.3":[152],"compared":[158,206,304],"to":[159,339],"membranes,":[162],"other":[165],"species":[166],"comparable.":[168],"stable":[170],"GTP":[171],"analogue,":[172],"Gpp(NH)p":[173],"(100":[174],"microM)":[175],"reduced":[176],"2-chloro-N6-cyclopentyladenosine":[177],"(CCPA)":[178],"7-13.9":[180],"fold,":[181],"whereas":[182],"DPCPX":[186],"unaffected.":[188],"4.":[189],"six":[193],"xanthine-based":[194],"antagonists":[197],"2.2-15.9":[199],"with":[207,305],"species-independent.":[218],"In":[219],"contrast,":[220],"three":[221],"pyrazolopyridine":[222,288,325],"derivatives,":[223,289],"(R)-1-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)":[224,228],"acryloyl]-2-piperidine":[225],"ethanol":[226],"(FK453),":[227],"acryloyl]-piperidin-2-yl":[229],"acetic":[230],"acid":[231,235],"(FK352)":[232],"6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)-pyridazinebutyric":[234],"(FK838)":[236],"similar":[238,344],"pKi":[248,295,306],"for":[251,268,346],"9.31,":[260,309],"7.52":[261],"7.92,":[263],"5.":[265],"Drug":[266],"A2A":[270],"determined":[273,313],"[3H]-2-[4-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamido":[276],"ade":[277],"nosine":[278],"([3H]-CGS":[279],"21680)":[280],"striatal":[285],"FK453,":[290],"FK838":[291],"FK352":[293],"5.90,":[299],"5.92":[300],"4.31,":[302],"respectively,":[303],"8.18":[310],"7.57":[312],"These":[323],"novel":[324],"derivatives":[326],"therefore":[327],"represent":[328],"high":[329],"affinity,":[330],"drugs":[335],"that,":[336],"contrast":[338],"xanthine":[340],"based":[341],"antagonists,":[342],"exhibit":[343],"rat,":[352]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1982199478","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
